RecruitingNCT05587361
Propranolol and nicotine patches during smoking-cue brain scans
About this title
Read the official source — NCT05587361Medication studyAges 21–60United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 21 years to 60 years.
What will I do during this study?
The protocol includes: Completing questionnaires.
- Listed locations
- TulsaSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: November 26, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 80
- Sponsor
- University of Oklahoma
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 21 Years to 60 Years
- Official registry ID
- NCT05587361
- Official title
Show the full official title
Beta-Adrenergic Modulation of Drug Cue Reactivity: Neural and Behavioral Mechanisms
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Tulsa
Questions about this study
What will I need to do?
You will complete questionnaires.
Who is behind this study?
The study sponsor is University of Oklahoma, a university.
Does this study involve medication?
Yes. The study involves medication, including Propranolol, Nicotine Patch, Placebo Propranolol and Placebo Patch.
Who can participate?
Listed age limits: 21 years to 60 years.
Is this study still recruiting?
The registry lists this study as recruiting.
